Antidepressant Equivalent Dose Calculator

Use this premium conversion tool to estimate an approximate equivalent daily dose when switching between common SSRIs and SNRIs. This calculator is designed for educational use and should support, not replace, individualized clinical judgment, tapering plans, and monitoring for withdrawal effects, serotonin toxicity, relapse, and drug interactions.

Dose Conversion Calculator

Clinical note: Dose equivalence is approximate. Actual switch strategy depends on indication, patient age, hepatic or renal function, prior response, adverse effects, comorbidities, interaction burden, half-life, and whether the transition is direct, tapered, or cross-tapered. Fluoxetine is especially important because of its long half-life.

Expert Guide to Using an Antidepressant Equivalent Dose Calculator

An antidepressant equivalent dose calculator helps estimate how one antidepressant dose compares with another when clinicians, pharmacists, or informed patients are reviewing a medication change. In practice, this is most useful when someone is switching from one selective serotonin reuptake inhibitor or serotonin-norepinephrine reuptake inhibitor to another and wants a rough idea of what a therapeutically similar dose might look like. These tools can improve medication discussions, make charts easier to interpret, and support safer transitions, but they should never be treated as rigid rules.

Antidepressants differ in receptor profile, half-life, active metabolites, discontinuation risk, and approved dose ranges. That means two medications can both be used for major depressive disorder yet still behave very differently in real patients. A calculator therefore provides a starting estimate, not a complete switching protocol. Clinicians still need to decide whether a direct switch, washout, cross-taper, or slow taper is the safest choice.

Key takeaway: Equivalent dose calculators are best used to generate an initial conversion estimate. The final prescribing decision should account for withdrawal risk, prior treatment response, side effect burden, age, liver and kidney function, pregnancy status, and concurrent medications.

Why Equivalent Dosing Matters

There are several common reasons a patient may need an antidepressant conversion estimate. A medication may be effective but poorly tolerated because of nausea, sexual dysfunction, sedation, sweating, insomnia, or weight change. Insurance formularies may change. Drug interactions may become more relevant after another medicine is added. Some patients also need a switch because they have had only a partial response after an adequate trial.

When changing therapy, clinicians try to preserve antidepressant effect while minimizing interruption and withdrawal symptoms. If the next medication is started too low, the patient may lose symptom control. If it is started too high, the risk of adverse effects goes up. Equivalent dose estimates help frame that decision, especially when a clinician wants to compare the relative intensity of serotonergic treatment across agents.

What This Calculator Assumes

This calculator uses a simple reference framework based on a common comparison point: fluoxetine 20 mg equivalent. In this model, approximate therapeutic equivalencies are:

• Fluoxetine 20 mg
• Sertraline 50 mg
• Paroxetine 20 mg
• Citalopram 20 mg
• Escitalopram 10 mg
• Fluvoxamine 100 mg
• Venlafaxine XR 75 mg
• Duloxetine 30 mg
• Desvenlafaxine 50 mg

Using these anchors, the calculator converts your current dose into a normalized reference value and then estimates the target dose. For example, if 50 mg of sertraline is considered roughly comparable to 20 mg of fluoxetine, then 100 mg of sertraline would map to about 40 mg fluoxetine equivalent. If the target is escitalopram, and 10 mg escitalopram is roughly equal to 20 mg fluoxetine, the target estimate would be about 20 mg escitalopram.

Important Limits of Antidepressant Equivalence

Equivalent dosing is inherently imperfect. Antidepressants are not interchangeable in the same way that many blood pressure medicines or antibiotics can be compared by simple milligram strength. Several factors limit precision:

1. Different pharmacology: SSRIs vary in anticholinergic effects, CYP inhibition, and activation or sedation profile. SNRIs add norepinephrine effects at certain doses.
2. Nonlinear experience: A patient who tolerates 40 mg of one medication may not tolerate the estimated equivalent of another.
3. Half-life differences: Fluoxetine and norfluoxetine persist for days to weeks, while paroxetine and venlafaxine have more prominent discontinuation syndromes.
4. Indication-specific dosing: Doses for panic disorder, obsessive-compulsive disorder, generalized anxiety disorder, and major depressive disorder may differ.
5. Formulation differences: Immediate-release and extended-release products may not be switched one-to-one in every circumstance.

Clinical Situations Requiring Extra Caution

• Switching from or to monoamine oxidase inhibitors
• History of serotonin syndrome
• Bipolar disorder or possible bipolar spectrum illness
• Pregnancy or breastfeeding
• Older adults with polypharmacy
• Hepatic impairment, renal impairment, or seizure risk
• Concurrent use of tramadol, linezolid, triptans, lithium, or other serotonergic agents

Approximate Reference Table for Common SSRIs and SNRIs

Medication	Approximate equivalent dose	Typical adult daily range	Selected pharmacology note
Fluoxetine	20 mg	20 to 80 mg	Long half-life; lower discontinuation risk but prolonged washout concerns
Sertraline	50 mg	50 to 200 mg	Common first-line SSRI with broad use in depression and anxiety disorders
Paroxetine	20 mg	20 to 50 mg	Higher anticholinergic burden and discontinuation risk than many SSRIs
Citalopram	20 mg	20 to 40 mg	QT-related dose considerations are clinically relevant at higher doses
Escitalopram	10 mg	10 to 20 mg	Often viewed as potent at lower milligram doses
Fluvoxamine	100 mg	100 to 300 mg	Strong interaction potential through CYP pathways
Venlafaxine XR	75 mg	75 to 225 mg	Discontinuation symptoms can be pronounced if stopped abruptly
Duloxetine	30 mg	30 to 120 mg	Useful when depression overlaps with neuropathic pain or fibromyalgia syndromes
Desvenlafaxine	50 mg	50 to 100 mg	Often prescribed at a relatively narrow usual dose range

Real Epidemiology and Treatment Context

Antidepressant conversion calculators matter because depression is common and treatment changes are common. According to the National Institute of Mental Health, an estimated 21.0 million adults in the United States experienced at least one major depressive episode in 2021, representing about 8.3% of all U.S. adults. Depression burden was not distributed equally across the population, which reinforces the need for individualized treatment planning rather than a one-size-fits-all medication approach.

Population statistic	Estimated value	Why it matters clinically
U.S. adults with at least one major depressive episode in 2021	21.0 million	Large absolute treatment population means medication switching is a frequent real-world task
Percent of U.S. adults with a major depressive episode in 2021	8.3%	Supports the need for practical, standardized tools that help structure prescribing decisions
Women with a major depressive episode in 2021	10.3%	Shows substantial prevalence and the importance of tailoring medication decisions to sex-specific tolerability and reproductive considerations
Men with a major depressive episode in 2021	6.2%	Confirms that depression affects all groups and careful long-term management remains essential
Adults ages 18 to 25 with a major depressive episode in 2021	18.6%	Younger adults often require close follow-up during medication starts, stops, and switches

These figures help explain why equivalent-dose tools are valuable in both primary care and mental health settings. Medication changes are not rare exceptions. They are part of routine longitudinal care. Even so, no calculator can account for all patient-specific variables. The most useful mindset is to treat the conversion as a clinically informed estimate that must be confirmed against the broader picture.

How to Use the Calculator Correctly

1. Select the current antidepressant.
2. Enter the current total daily dose in milligrams.
3. Choose the target antidepressant.
4. Optionally choose a rounding preference to align the estimate with available dosage forms.
5. Click Calculate Equivalent Dose.
6. Review the result, the normalized fluoxetine-equivalent value, and the chart.

Remember that a mathematically equivalent target dose does not automatically equal the ideal starting dose. For a frail older adult, someone with multiple sedating medications, or a patient with previous activation on antidepressants, clinicians often start lower than the calculated estimate and titrate upward. By contrast, a patient already stable on a high serotonergic burden may need a more assertive cross-taper plan to avoid symptom rebound.

Examples of Practical Interpretation

• Sertraline 100 mg to escitalopram: Since 50 mg sertraline is roughly comparable to 10 mg escitalopram, 100 mg sertraline maps to about 20 mg escitalopram.
• Fluoxetine 40 mg to venlafaxine XR: If 20 mg fluoxetine corresponds to 75 mg venlafaxine XR, then 40 mg fluoxetine maps to roughly 150 mg venlafaxine XR.
• Duloxetine 60 mg to sertraline: If 30 mg duloxetine is roughly equivalent to 50 mg sertraline, then 60 mg duloxetine corresponds to about 100 mg sertraline.

Why Chart Visualization Helps

The chart beneath the calculator compares three clinically meaningful values: your entered source dose, the estimated target dose, and the fluoxetine-equivalent reference dose. Visualizing those numbers makes it easier to understand whether a proposed conversion represents a lateral switch, an apparent escalation, or a de-escalation in antidepressant intensity. In medication reviews, this is especially useful when patients have records from multiple clinicians using different drugs over time.

Best Practices for Switching Antidepressants

Although the exact approach varies, safe antidepressant transitions often follow a few broad principles:

• Confirm the reason for switching: inefficacy, adverse effects, interactions, preference, cost, or pregnancy planning.
• Review prior medication trials and what happened at each dose.
• Assess adherence before labeling a medication ineffective.
• Consider half-life and discontinuation risk before deciding on direct switch versus taper.
• Educate patients on expected side effects, withdrawal symptoms, and warning signs.
• Schedule follow-up, especially during the first few weeks after the switch.

Symptoms That Need Urgent Review

• Agitation, tremor, sweating, fever, or confusion suggesting serotonin toxicity
• Severe dizziness, electric shock sensations, or marked anxiety after abrupt cessation
• New suicidal thinking, self-harm thoughts, or sudden behavioral change
• Mania symptoms such as decreased need for sleep, impulsivity, pressured speech, or grandiosity

Authoritative Resources

For evidence-based background, review: NIMH major depression statistics, MedlinePlus antidepressant information, and the VA/DoD guideline for major depressive disorder.

Bottom Line

An antidepressant equivalent dose calculator is a practical clinical support tool. It helps translate one regimen into another using a consistent reference framework, improves communication during medication reviews, and supports safer prescribing conversations. Its greatest value is clarity, not certainty. If you are switching treatment, use the conversion estimate as the beginning of a decision-making process that also considers tapering strategy, patient history, side effects, interactions, and close follow-up.